BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23394073)

  • 1. Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma.
    Wang Y; Zhang R; Wu D; Lu Z; Sun W; Cai Y; Wang C; Jin J
    J Exp Clin Cancer Res; 2013 Feb; 32(1):8. PubMed ID: 23394073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of low expression of hMOF with clinicopathological features of colorectal carcinoma, gastric cancer and renal cell carcinoma.
    Cao L; Zhu L; Yang J; Su J; Ni J; Du Y; Liu D; Wang Y; Wang F; Jin J; Cai Y
    Int J Oncol; 2014 Apr; 44(4):1207-14. PubMed ID: 24452485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hMOF, but not HDAC4, is responsible for the global histone H4K16 acetylation in gastric carcinoma.
    Zhu L; Yang J; Zhao L; Yu X; Wang L; Wang F; Cai Y; Jin J
    Int J Oncol; 2015; 46(6):2535-45. PubMed ID: 25873202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma.
    Pfister S; Rea S; Taipale M; Mendrzyk F; Straub B; Ittrich C; Thuerigen O; Sinn HP; Akhtar A; Lichter P
    Int J Cancer; 2008 Mar; 122(6):1207-13. PubMed ID: 18058815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential diagnostic marker for ovarian cancer: Involvement of the histone acetyltransferase, human males absent on the first.
    Liu N; Zhang R; Zhao X; Su J; Bian X; Ni J; Yue Y; Cai Y; Jin J
    Oncol Lett; 2013 Aug; 6(2):393-400. PubMed ID: 24137335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hMOF-dependent histone H4 lysine 16 acetylation in the maintenance of TMS1/ASC gene activity.
    Kapoor-Vazirani P; Kagey JD; Powell DR; Vertino PM
    Cancer Res; 2008 Aug; 68(16):6810-21. PubMed ID: 18701507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone acetyltransferase hMOF suppresses hepatocellular carcinoma growth.
    Zhang J; Liu H; Pan H; Yang Y; Huang G; Yang Y; Zhou WP; Pan ZY
    Biochem Biophys Res Commun; 2014 Sep; 452(3):575-80. PubMed ID: 25181338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma.
    Poté N; Cros J; Laouirem S; Raffenne J; Negrão M; Albuquerque M; Bedossa P; Godinho Ferreira M; Ait Si Ali S; Fior R; Paradis V
    Liver Int; 2020 Apr; 40(4):956-967. PubMed ID: 31943753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.
    Hajji N; Wallenborg K; Vlachos P; Füllgrabe J; Hermanson O; Joseph B
    Oncogene; 2010 Apr; 29(15):2192-204. PubMed ID: 20118981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.
    Chen Z; Ye X; Tang N; Shen S; Li Z; Niu X; Lu S; Xu L
    Br J Pharmacol; 2014 Jul; 171(13):3196-211. PubMed ID: 24571482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone acetyltransferase hMOF promotes S phase entry and tumorigenesis in lung cancer.
    Zhao L; Wang DL; Liu Y; Chen S; Sun FL
    Cell Signal; 2013 Aug; 25(8):1689-98. PubMed ID: 23628702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
    Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
    Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.
    Banerjee A; Mahata B; Dhir A; Mandal TK; Biswas K
    J Biol Chem; 2019 Jan; 294(3):1005-1018. PubMed ID: 30463940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
    Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Björkholm M; Liu Z; Xu D
    Mol Cancer Res; 2007 Aug; 5(8):793-800. PubMed ID: 17699105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.
    Hong Z; Li H; Li L; Wang W; Xu T
    Cancer Biomark; 2017; 18(2):125-131. PubMed ID: 27983522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulations of hMOF autoacetylation by SIRT1 regulate hMOF recruitment and activities on the chromatin.
    Lu L; Li L; Lv X; Wu XS; Liu DP; Liang CC
    Cell Res; 2011 Aug; 21(8):1182-95. PubMed ID: 21502975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic Trioxide Reduces Global Histone H4 Acetylation at Lysine 16 through Direct Binding to Histone Acetyltransferase hMOF in Human Cells.
    Liu D; Wu D; Zhao L; Yang Y; Ding J; Dong L; Hu L; Wang F; Zhao X; Cai Y; Jin J
    PLoS One; 2015; 10(10):e0141014. PubMed ID: 26473953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.
    Zhang X; Peng D; Xi Y; Yuan C; Sagum CA; Klein BJ; Tanaka K; Wen H; Kutateladze TG; Li W; Bedford MT; Shi X
    Nat Commun; 2016 Mar; 7():10810. PubMed ID: 26960573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma.
    Matsuura K; Nakada C; Mashio M; Narimatsu T; Yoshimoto T; Tanigawa M; Tsukamoto Y; Hijiya N; Takeuchi I; Nomura T; Sato F; Mimata H; Seto M; Moriyama M
    BMC Cancer; 2011 Dec; 11():523. PubMed ID: 22185343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.